Article Figures & Data
Figures
- Fig 1.
Modified Rankin scale 0–2 outcomes in pre-IMS, IMS I, and IMS II compared with historical control of NINDS study rtPA and placebo control groups. Time to IV treatment was significantly earlier in the NINDS rtPA trial (108 minutes) compared with that in the 3 IV/IA treatment groups (126, 139, 140 minutes).
- Fig 2.
Percentage modified Rankin scale 0–2 compared with onset to IA rtPA bolus (following reduced-dose IV therapy). A trend toward better outcomes with earlier therapy is demonstrated. No difference of post-IV IA therapy begun at 4–5 hours, compared with IV therapy (NINDS rtPA), is also shown. In IMS I and II, IA therapy began within 5 hours.
- Fig 3.
Percentage modified Rankin scale 0–2 versus baseline NIHSS score. Improved outcomes at higher NIHSS scores in pre-IMS and IMS I are achieved.
In this issue
Related Articles
Cited By...
- Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data
- Capillary Index Score in the Interventional Management of Stroke Trials I and II
- Equipoise among recanalization strategies
- Intra-Arterial Stroke Therapy: An Assessment of Demand and Available Work Force